The AI-Assisted Identification and Clinical Efficacy of Baricitinib in the Treatment of COVID-19

During the current pandemic, the vast majority of COVID-19 patients experienced mild symptoms, but some had a potentially fatal aberrant hyperinflammatory immune reaction characterized by high levels of IL-6 and other cytokines. Modulation of this immune reaction has proven to be the only method of...

Descripción completa

Detalles Bibliográficos
Autores principales: Richardson, Peter J., Robinson, Bruce W. S., Smith, Daniel P., Stebbing, Justin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231077/
https://www.ncbi.nlm.nih.gov/pubmed/35746559
http://dx.doi.org/10.3390/vaccines10060951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231077/
https://www.ncbi.nlm.nih.gov/pubmed/35746559
http://dx.doi.org/10.3390/vaccines10060951

Ejemplares similares